| 20/12/2013 |
Cleansing Notice and Appendix 3B |
| 18/12/2013 |
Results of Completed CK3000 Diagnostic Study |
| 11/12/2013 |
$2 Million Capital Raising |
| 25/11/2013 |
Appendix 3B and Change of Interests of Substantial Holding |
| 25/11/2013 |
Change of Director’s Interest Notice – Maria Halasz |
| 25/11/2013 |
Cleansing Statement |
| 22/11/2013 |
AGM Presentation by CEO |
| 22/11/2013 |
Results of Meeting |
| 20/11/2013 |
Change in substantial holding |
| 18/11/2013 |
Proposed Issue of Shares |
| 30/10/2013 |
Release of Shares from Voluntary Escrow |
| 23/10/2013 |
Appendix 4C – quarterly |
| 21/10/2013 |
Annual Report to Shareholders |
| 21/10/2013 |
Notice of Annual General Meeting and Proxy Form |
| 18/10/2013 |
Key Antibody Patent Granted in Japan |
| 08/10/2013 |
Key European Patent for Anti-Midkine Antibodies Granted |
| 04/10/2013 |
R&D Tax refund received |
| 03/10/2013 |
Midkine antibodies effective in cancer |
| 20/09/2013 |
Cellmid Signs Major Japanese Distribution Agreement |
| 19/09/2013 |
Independent Valuation Report of Advangen Inc Japan |
| 18/09/2013 |
Cellmid CEO Presents at Brokers Meet Biotech |
| 10/09/2013 |
Date of Annual General Meeting |
| 03/09/2013 |
Change in substantial holding |
| 28/08/2013 |
Appendix 4E and Preliminary Final Report |
| 01/08/2013 |
Cellmid Received Pacific Edge Milestone Shares |
| 29/07/2013 |
Cellmid Collaborates on Early Diagnosis of Colorectal Cancer |
| 26/07/2013 |
Appendix 4C – quarterly |
| 22/07/2013 |
Release of Shares from Voluntary Escrow |
| 18/07/2013 |
Fujikura Exercises Option To License Cellmid’s Diagnostics |
| 16/07/2013 |
Appointment of Company Secretary |
| 04/07/2013 |
Change of Director’s Interest Notice |
| 12/06/2013 |
Change of Director’s Interest Notice |
| 28/05/2013 |
Settlement of Advangen Inc Acquisition Completed |
| 20/05/2013 |
Cellmid News |
| 08/05/2013 |
Advangen Acquisition |
| 08/05/2013 |
CEO Presentation |
| 30/04/2013 |
Change of Company Address |
| 22/04/2013 |
Appendix 4C – quarterly |
| 08/04/2013 |
Resignation of Company Secretary |
| 26/03/2013 |
Cellmid Diagnostic Licenses Update |
| 22/03/2013 |
Appendix 3B |
| 13/03/2013 |
Cellmid Completes $2M Placement |
| 04/03/2013 |
Change in Director’s Interest – M Halasz |
| 19/02/2013 |
Change in Director’s Interest – M Rogers |
| 11/02/2013 |
Cellmid Signs Midkine Diagnostic Agreement |
| 29/01/2013 |
Appendix 4C Quarterly report |
| 29/01/2013 |
Cellmid News |
| 23/01/2013 |
Positive Data in Midkine Antibody Study in Kidney Disease |
| 21/01/2013 |
European Patent Allowed for Treating Vascular Occlusive Disease |
| 11/01/2013 |
Change in Director’s Interest – M Halasz |
| 07/01/2013 |
Change in Director’s Interest – M Halasz |
